Last reviewed · How we verify
NCT05679635
Evaluation of Tracheal Pressure During CPAP
NA trial testing Evone in Continuous Positive Airway Pressure in 20 participants. Completed in 14 May 2024.
14 May 2024
Quick facts
| Lead sponsor | Medical University Innsbruck |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 20 |
| Start date | 24 November 2022 |
| Primary completion | 14 May 2024 |
| Estimated completion | 14 May 2024 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Evone
- Evita Infinity V500
Conditions studied
- Continuous Positive Airway Pressure — all drugs for Continuous Positive Airway Pressure →
- CPAP Ventilation — all drugs for CPAP Ventilation →
Sponsor
Medical University Innsbruck
Who can join
18 and older, any sex, with Continuous Positive Airway Pressure or CPAP Ventilation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial evaluates tracheal pressure values in intubated intensive care unit patients during continuous positive airway pressure without any ventilatory support, automatic tube compensation and assisted spontaneous breathing.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05679635
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Evone
Trials testing the same drug.
- NCT06222463 — Power Dissipation in Flow-controlled Ventilation · NA · unknown
- NCT04534933 — Flow Controlled Ventilation in Thoracic Surgery · NA · completed
- NCT04306757 — Flow Controlled Ventilation in Cardiac Surgery · NA · completed
Other recruiting trials for Continuous Positive Airway Pressure
Currently open trials in the same condition.
- NCT06570629 — Addressing Unintentional Leakage When Using Nasal CPAP - Study B · NA · recruiting
- NCT06570616 — Addressing Unintentional Leakage When Using Nasal CPAP - Study A · NA · recruiting
- NCT06542263 — Clinical Study on the Effect of CPAP on AF Recurrence After Catheter Ablation in Patients with AF and OSA · recruiting
Other Medical University Innsbruck trials
Trials by the same sponsor.
- NCT07408726 — Monoaxial vs. Polyaxial Percutaneous Hybrid Stabilization · NA · not yet recruiting
- NCT07101107 — Socio-cognitive and Biological Responses to Maltreatment · not yet recruiting
- NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
- NCT07434648 — Comparison of Mastectomy Expander Trial · NA · not yet recruiting
- NCT07391683 — Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05679635 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University Innsbruck
- Last refreshed: 28 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05679635.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing